Jennifer Treleaven

Disease evolution and outcomes in familial AML with germline CEBPA mutations

Kiran Tawana, Jun Wang, Aline Renneville et al. · Blood · 2015 · 194 citations · Full text

Life Sciences, Genetics, Oncology +16

A randomized trial of maintenance interferon following high‐dose chemotherapy in multiple myeloma: long‐term follow‐up results

David Cunningham, R Powles, J. S. Malpas et al. · British Journal of Haematology · 1998 · 168 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Prevention of breast cancer with tamoxifen—an update on the royal Marsden Hospital pilot programme

Trevor J. Powles, C R Tillyer, Alison L. Jones et al. · European Journal of Cancer and Clinical Oncology · 1990 · 160 citations

Medicine, Gynecology, Oncology +14

Identification of Patients Who May Benefit From Prophylactic Immunotherapy After Bone Marrow Transplantation for Acute Myeloid Leukemia on the Basis of Lymphocyte Recovery Early After Transplantation

R Powles, Seema Singhal, Jennifer Treleaven et al. · Blood · 1998 · 124 citations · Full text

Medicine, Hematology, Immunology +16

Long‐term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high‐dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatments

Caroline Alvares, Faith E. Davies, C Horton et al. · British Journal of Haematology · 2005 · 49 citations · Full text

Medicine, Hematology, Pharmacotherapy +12